These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6991918)

  • 1. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E; Hyman J; Rosenkranz HS
    Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
    Gold MD; Blum A; Ames BN
    Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
    Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
    Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.
    Dybing E; Søderlund E
    Arch Toxicol Suppl; 1980; 4():219-22. PubMed ID: 6933906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of derivatives of the flame retardant tris(2,3-dibromopropyl) phosphate: halogenated propanols.
    Carr HS; Rosenkranz HS
    Mutat Res; 1978 Jul; 57(3):381-4. PubMed ID: 353552
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites.
    Elliott WC; Lynn RK; Houghton DC; Kennish JM; Bennett WM
    Toxicol Appl Pharmacol; 1982 Jan; 62(1):179-82. PubMed ID: 7064152
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrotoxicity and hepatotoxicity of tris(2,3-dibromopropyl)phosphate in the rat.
    Söderlund E; Dybing E; Nelson SD
    Toxicol Appl Pharmacol; 1980 Nov; 56(2):171-81. PubMed ID: 7466817
    [No Abstract]   [Full Text] [Related]  

  • 9. Tris(2,3-dibromopropyl) phosphate: mutagenicity of a widely used flame retardant.
    Prival MJ; McCoy EC; Gutter B; Rosendranz HS
    Science; 1977 Jan; 195(4273):76-8. PubMed ID: 318761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sister chromatid exchanges and growth inhibition induced by the flame retardant tris(2,3-dipromopropyl) phosphate in Chinese hamster cells.
    Furukawa M; Sirianni SR; Tan JC; Huang CC
    J Natl Cancer Inst; 1978 May; 60(5):1179-81. PubMed ID: 642035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tris(2,3-dibromopropyl) phosphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():575-88. PubMed ID: 397179
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
    Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
    Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein.
    van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH
    Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flame retardant tris (2, 3-dibromopropyl) phosphate: alteration of human cellular DNA.
    Gutter B; Rosenkranz HS
    Mutat Res; 1977 Sep; 56(1):89-90. PubMed ID: 593298
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system.
    Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T
    Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal oxidative degradation studies of phosphate esters.
    Paciorek KJ; Kratzer RH; Kaufman J; Nakahara JH; Christos T; Hartstein AM
    Am Ind Hyg Assoc J; 1978 Aug; 39(8):633. PubMed ID: 696625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tris(2-chloroethyl) phosphate.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():109-20. PubMed ID: 2197455
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
    Zeiger E; Pagano DA; Nomeir AA
    Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in kidney toxicity and metabolic activation of tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Nelson SD; von Bahr C; Dybing E
    Fundam Appl Toxicol; 1982; 2(4):187-94. PubMed ID: 7185616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.